Neurocrine Biosciences

Motion blurs of people hurrying around an office

Marketing

Neurocrine data make case for timely movement disorder diagnosis

Neurocrine shared survey data showing how tardive dyskinesia affects patients' and caregivers' work, supporting its case for timely treatment.

Nick Paul Taylor May 5, 2026 6:03am

A chessboard with blocks that read MA

Neurocrine pays $2.9B for Soleno, its largest M&A deal ever

Apr 6, 2026 10:30am

Lifeline

Fierce Biotech

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm

dart board miss failure

Neurocrine's Ingrezza misses in cerebral palsy trial

Dec 23, 2025 10:20am

Neurocrine Biosciences Carnie Wilson tardive dyskinesia campaign

Neurocrine taps Wilson Phillips star for tardive dyskinesia push

May 6, 2025 11:16am

Neurocrine

Neurocrine's Ingrezza guidance spooks investors

Feb 10, 2025 9:13am